Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

15.71
+0.20001.29%
Volume:8.05M
Turnover:126.35M
Market Cap:18.02B
PE:-10.83
High:15.88
Open:15.59
Low:15.45
Close:15.51
Loading ...

Axsome Therapeutics Shares Rise After Agreement with Teva Pharmaceuticals Ends Litigation

Dow Jones
·
10 Feb

Axsome, Teva Settle Auvelity Patent Litigation

MT Newswires Live
·
10 Feb

Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals

Business Wire
·
10 Feb

Medincell: Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals

Business Wire
·
10 Feb

Teva Pharmaceutical Industries Files Mixed Shelf Registration

MT Newswires Live
·
08 Feb

Teva files automatic mixed securities shelf

TIPRANKS
·
08 Feb

Teva Pharmaceutical Industries Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
07 Feb

Saverone 2014 Wins Contract To Equip Teva Pharmaceutical's 50-Truck Fleet With Safety System

MT Newswires Live
·
04 Feb

SaverOne Expands Driver Safety System Deployment with Teva Pharmaceutical

TIPRANKS
·
04 Feb

Saverone Announces New Deployment of Its Driver Distraction Prevention System in Teva Pharmaceutical’s Truck Fleet

THOMSON REUTERS
·
04 Feb

SaverOne Announces New Deployment of Its Driver Distraction Prevention System in Teva Pharmaceutical’s Truck Fleet

GlobeNewswire
·
04 Feb

Teva Pharmaceutical (TEVA) Gets a Buy from Argus Research

TIPRANKS
·
31 Jan

Teva Pharmaceutical Industries Ltd (TEVA) Q4 2024 Earnings Call Highlights: Strong Revenue ...

GuruFocus.com
·
31 Jan

Teva’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
31 Jan

Stock Track | Teva Pharmaceutical Plummets 5% on Disappointing 2025 Earnings Guidance Despite Solid Q4 Results

Stock Track
·
31 Jan

TEVA Stock Down 14% Despite Q4 Earnings & Revenues Beat Estimates

Zacks
·
31 Jan

Why Teva Pharmaceuticals (TEVA) Crashed on Wednesday?

Insider Monkey
·
30 Jan

Teva Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
30 Jan

Teva Pharmaceutical Industries Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
30 Jan

Teva price target lowered to $26 from $28 at Barclays

TIPRANKS
·
30 Jan